← All organizations

the Flanders Institute for Biotechnology

Academic/Hospital

Also known as: Flanders Institute of Biotechnology | the Flanders Institute for Biotechnology

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Mar 24, 2020

Timeline

No events for the selected filters.

Drugs by trial phase (4 distinct, 3 trials)

Phase 4 (1 own, 0 via acquisition)

sargramostim

Phase 3 (1 own, 0 via acquisition)

golimumab

Other trials (2 own, 0 via acquisition)

Indications

Studied for

Recent trials (3)

NCT04326920CollaboratorPhase 4Mar 24, 2020
NCT03808389CollaboratorN/AJan 30, 2019
NCT03270501CollaboratorPhase 3Sep 30, 2017

Details

Last known activity: Mar 24, 2020